Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Combination 2ME2 and Taxotere trial begins

Sep. 19, 2000

Japanese lab identifies benzimidazole-based antitumor agents

Sep. 18, 2000

Kirin Brewery investigates antitumor activity of quinoline and quinazoline derivatives

Sep. 18, 2000

Derivatives of 4-demethylpenclomedine useful as antitumor agents

Sep. 18, 2000

Stem cell transplant benefits some renal cell carcinoma patients

Sep. 18, 2000

OSI's ERF receptor inhibitor continues to demonstrate anticancer activity and good safety

Sep. 15, 2000

Antibody and protein therapeutics for breast cancer sought by Eos and Biogen collaboration

Sep. 15, 2000

Oleander extract selectively kills human cancer cells via an effect on TRF2

Sep. 15, 2000

Protein-peptide fusion stimulates anticancer activity without adjuvant

Sep. 15, 2000

Exclusive access to technology for potential cancer vaccine granted to Viragen

Sep. 14, 2000

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...